Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3

Area of Science:

• Molecular Biology
• Cancer Research
• Signaling Pathways

Background:

• The Ras/MAPK signaling pathway is crucial for cell growth and proliferation.
• This pathway is often dysregulated in cancers, particularly melanoma.
• RSK (p90 ribosomal S6 kinase) is a key effector kinase in this pathway, vital for melanoma progression, but its substrates and functions remain largely unelucidated.

Purpose of the Study:

• To identify RSK-regulated signaling networks in melanoma using quantitative phosphoproteomics.
• To characterize the RSK consensus phosphorylation motif and its relationship with 14-3-3 protein binding.
• To investigate the role of RSK in regulating the tumor suppressor PDCD4 (programmed cell death protein 4).

Main Methods:

• Quantitative phosphoproteomics to map RSK-dependent phosphorylation sites.
• Determination of the RSK consensus phosphorylation motif.
• Characterization of the phospho-dependent 14-3-3 interactome in melanoma cells.

Main Results:

• RSK directly phosphorylates PDCD4 (programmed cell death protein 4) at Ser76 and Ser457.
• This phosphorylation event regulates PDCD4's subcellular localization and interaction with 14-3-3 proteins.
• 14-3-3 binding to phosphorylated PDCD4 promotes its degradation, implicating RSK in PDCD4 inactivation.

Conclusions:

• RSK plays a significant role in melanoma pathogenesis by inactivating the tumor suppressor PDCD4.
• The study reveals RSK's involvement in a broad range of biological functions relevant to oncogenesis.
• RSK's phosphorylation motif overlaps with 14-3-3 binding motifs, highlighting a key regulatory mechanism.